Skip to main content

Genome Medical: Brandon Poe, Marco Barcella, Russell Glass

South San Francisco-based digital health firm Genome Medical has made appointments to its management team and board of directors.

Brandon Poe has become the company's CFO. Previously, he was VP of finance at Illumina, and before that, CFO of medical device firm Sotera Wireless. He holds an MBA from the University of Chicago Booth School of Business and a bachelor's degree from Bucknell University.

Marco Barcella has been appointed as Genome Medical's chief product officer. Most recently, he held strategic product positions at Tiatros and at IBM Watson Health. He holds an MBA from the NYU Stern School of Business and a master of science degree from the University of Virginia.

Russell Glass has joined the firm as an independent director. He is the CEO of on-demand mental health company Ginger. Prior to that, he was the founder and CEO of Bizo, a B2B marketing and data firm that was sold to LinkedIn in 2014, which he then joined.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.